RxDoctor Payments DataLook up a doctor →

Andrew Sulich, MD

Rheumatology · Saint Clair Shores, MINPI 1508946385

Payments from drug & device makers

$3,367,749in general payments, 2019–2025

Across 3,870 payments — averaging $870.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$928K
  • Amgen$516K
  • AstraZeneca$404K
  • Gilead$232K
  • UCB, Inc.$216K
  • AbbVie$161K
  • plus $912K from 49 others
$872in research payments, 2019–2025

Across 5 payments — averaging $174.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$788
  • Gilead$84

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis325$927,665
Amgen(2 entities)482$515,810
AstraZeneca(2 entities)419$403,616
Gilead71$232,411
UCB, Inc.472$215,780
AbbVie325$160,576
Lilly USA, LLC270$146,059
Bristol Myers Squibb109$142,027
GSK201$111,256
Eli Lilly5$89,325
UCB SA4$86,509
ANI Pharmaceuticals, Inc.131$67,226
Sanofi86$56,397
Aurinia Pharma U.S., Inc.56$35,158
Regeneron Healthcare Solutions, Inc.60$35,086
Genentech USA, Inc.57$31,981
Takeda Pharmaceuticals U.S.A., Inc.6$19,950
Sobi, Inc47$19,261
Johnson & Johnson223$18,701
Hoffmann-la Roche Limited6$18,259
E.r. Squibb & Sons, L.L.C.195$9,023
Sanofi US Services Inc.5$8,940
Pfizer176$6,687
Genentech, Inc.3$3,088
Kiniksa Pharmaceuticals, Ltd.2$3,021
Pacira Pharmaceuticals Incorporated3$565
Sandoz19$479
Organon23$412
Janssen Scientific Affairs, LLC5$303
Dr.reddy's Laboratories,inc.1$300
Mallinckrodt Hospital Products Inc.16$244
Cardinal Health 110 LLC2$200
Fresenius Kabi USA, LLC9$182
United Therapeutics Corporation2$121
Pacira Therapeutics, Inc.5$111
Amneal Pharmaceuticals LLC1$100
Alvogen Inc5$93
Hikma Pharmaceuticals USA7$92
Cardinal Health 108 LLC1$87
Actelion Pharmaceuticals US, Inc.3$76
Sanofi-aventis U.S. LLC5$74
Boehringer Ingelheim4$70
Antares Pharma, Inc.3$51
Mallinckrodt Enterprises LLC3$50
Ferring Pharmaceuticals Inc.3$48
Kiniksa Pharmaceuticals International, PLC2$48
Arcutis Biotherapeutics, Inc.2$42
Mylan Institutional Inc.2$41
Merck2$34
Kyowa Kirin, Inc.1$26
Zimmer Biomet1$21
Alnylam Pharmaceuticals Inc.1$20
Celltrion USA Inc.1$18
Radius Health, Inc.1$16
Sebela Pharmaceuticals Inc.1$11

How this compares

$3,367,749 in reported general payments places this provider in the 95th percentile of 195 rheumatology providers in Michigan.

See all rheumatology providers in Michigan

Medicare billing

Part B allowed, 2024
$2,467,236
Medicare patients
466
Services billed
210,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Saint Clair Shores

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →